[go: up one dir, main page]

ATE423119T1 - Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung - Google Patents

Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung

Info

Publication number
ATE423119T1
ATE423119T1 AT06778710T AT06778710T ATE423119T1 AT E423119 T1 ATE423119 T1 AT E423119T1 AT 06778710 T AT06778710 T AT 06778710T AT 06778710 T AT06778710 T AT 06778710T AT E423119 T1 ATE423119 T1 AT E423119T1
Authority
AT
Austria
Prior art keywords
pyridoä2
düpyrimidine
derivatives
production
therapeutic use
Prior art date
Application number
AT06778710T
Other languages
English (en)
Inventor
Pierre Casellas
Bernard Bourrie
Pierre Perreaut
Claude Muneaux
Samir Jegham
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE423119T1 publication Critical patent/ATE423119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06778710T 2005-07-01 2006-06-29 Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung ATE423119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0507032A FR2887882B1 (fr) 2005-07-01 2005-07-01 Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique

Publications (1)

Publication Number Publication Date
ATE423119T1 true ATE423119T1 (de) 2009-03-15

Family

ID=36096420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778710T ATE423119T1 (de) 2005-07-01 2006-06-29 Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung

Country Status (40)

Country Link
US (2) US7504406B2 (de)
EP (2) EP1902054B1 (de)
JP (1) JP4472009B2 (de)
KR (1) KR101298344B1 (de)
CN (2) CN101213196B (de)
AR (1) AR054812A1 (de)
AT (1) ATE423119T1 (de)
AU (1) AU2006264801B2 (de)
BR (1) BRPI0613020A2 (de)
CA (1) CA2610794C (de)
CR (1) CR9568A (de)
CY (2) CY1110457T1 (de)
DE (1) DE602006005246D1 (de)
DK (2) DK1902054T3 (de)
DO (1) DOP2006000145A (de)
EA (1) EA014312B1 (de)
EC (1) ECSP078011A (de)
ES (2) ES2322101T3 (de)
FR (1) FR2887882B1 (de)
HR (2) HRP20090236T1 (de)
IL (1) IL187900A0 (de)
JO (1) JO2550B1 (de)
MA (1) MA29561B1 (de)
ME (1) ME01813B (de)
MX (1) MX2007016239A (de)
MY (1) MY143089A (de)
NO (1) NO20080418L (de)
NZ (1) NZ564072A (de)
PA (1) PA8684801A1 (de)
PE (1) PE20070139A1 (de)
PL (2) PL2020410T3 (de)
PT (2) PT1902054E (de)
RS (2) RS53211B (de)
SI (2) SI2020410T1 (de)
TN (1) TNSN07440A1 (de)
TW (1) TWI321566B (de)
UA (1) UA92021C2 (de)
UY (1) UY29645A1 (de)
WO (1) WO2007003765A1 (de)
ZA (1) ZA200711032B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
CA2739901A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators
WO2010043000A1 (en) * 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators and their use thereof
FR2948568B1 (fr) 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CN103204827B (zh) 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
EP2638911A1 (de) 2012-03-14 2013-09-18 Sanofi Neuartige Kombinationen zur Behandlung von akuter myeloischer Leukämie oder chronischer myeloischer Leukämie
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) * 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
HUT76853A (en) * 1994-11-14 1997-12-29 Warner Lambert Co 6-aryl pyrido[2,3-d]pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation and pharmaceutical compositions containing the same
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
OA12161A (en) * 2000-01-25 2006-05-08 Warner Lambert Co PyridoÄ2,3-dÜpyrimidine-2,7-diamine kinase inhibitors.
HUP0300136A2 (en) * 2000-03-06 2003-05-28 Warner Lambert Co 5-alkylpyrido [2,3-d]pyrimidines tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
DE60135854D1 (de) 2000-08-04 2008-10-30 Warner Lambert Co 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-one
US20030105115A1 (en) * 2001-06-21 2003-06-05 Metcalf Chester A. Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
US20050009849A1 (en) 2003-01-03 2005-01-13 Veach Darren R. Pyridopyrimidine kinase inhibitors
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr) * 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

Also Published As

Publication number Publication date
CA2610794C (fr) 2012-02-21
JO2550B1 (en) 2010-09-05
HRP20090236T1 (hr) 2009-05-31
JP2008544975A (ja) 2008-12-11
PA8684801A1 (es) 2007-01-17
NZ564072A (en) 2012-02-24
SI1902054T1 (sl) 2009-06-30
US20090163522A1 (en) 2009-06-25
PE20070139A1 (es) 2007-03-07
CY1110457T1 (el) 2015-04-29
EA200800223A1 (ru) 2008-06-30
BRPI0613020A2 (pt) 2010-12-14
TW200745102A (en) 2007-12-16
UA92021C2 (ru) 2010-09-27
EP1902054A1 (de) 2008-03-26
CR9568A (es) 2008-02-20
US20080176874A1 (en) 2008-07-24
IL187900A0 (en) 2008-03-20
KR20080021714A (ko) 2008-03-07
RS53211B (en) 2014-08-29
JP4472009B2 (ja) 2010-06-02
ES2450067T3 (es) 2014-03-21
DE602006005246D1 (de) 2009-04-02
RS50781B (sr) 2010-08-31
CN101213196A (zh) 2008-07-02
WO2007003765A1 (fr) 2007-01-11
PT2020410E (pt) 2014-03-20
NO20080418L (no) 2008-03-28
ES2322101T3 (es) 2009-06-16
CA2610794A1 (fr) 2007-01-11
CN102260258A (zh) 2011-11-30
TWI321566B (en) 2010-03-11
DOP2006000145A (es) 2008-01-31
ZA200711032B (en) 2009-04-29
PL2020410T3 (pl) 2014-05-30
MA29561B1 (fr) 2008-06-02
HK1122797A1 (en) 2009-05-29
FR2887882B1 (fr) 2007-09-07
PT1902054E (pt) 2009-04-22
CN102260258B (zh) 2015-01-07
EA014312B1 (ru) 2010-10-29
HRP20140246T1 (hr) 2014-06-20
TNSN07440A1 (en) 2009-03-17
US7504406B2 (en) 2009-03-17
SI2020410T1 (sl) 2014-04-30
UY29645A1 (es) 2007-01-31
DK2020410T3 (en) 2014-03-24
FR2887882A1 (fr) 2007-01-05
EP2020410B1 (de) 2013-12-18
EP2020410A1 (de) 2009-02-04
DK1902054T3 (da) 2009-06-15
KR101298344B1 (ko) 2013-08-20
ME01813B (me) 2014-09-20
PL1902054T3 (pl) 2009-07-31
US8008310B2 (en) 2011-08-30
EP1902054B1 (de) 2009-02-18
AU2006264801B2 (en) 2012-05-10
MY143089A (en) 2011-03-15
CN101213196B (zh) 2011-09-07
AU2006264801A1 (en) 2007-01-11
ECSP078011A (es) 2008-01-23
MX2007016239A (es) 2008-03-06
AR054812A1 (es) 2007-07-18
CY1114989T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
ATE372998T1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
ATE453637T1 (de) N-(aminoheteroaryl)-1h-indol-2-carboxamid- derivate sowie deren herstellung und therapeutische anwendung
DE602005006815D1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
ATE423119T1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
ATE461930T1 (de) Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung
ATE469131T1 (de) Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung
ATE467633T1 (de) 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
ATE441635T1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
ATE412635T1 (de) Diphenylpyridinderivate, deren herstellung und deren therapeutische anwendung
ATE325122T1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
ATE409184T1 (de) Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung
ATE475661T1 (de) Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung
ATE548349T1 (de) In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
ATE420072T1 (de) Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
DE602006015675D1 (de) 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung
ATE531715T1 (de) 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
DE602005019743D1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
ATE520654T1 (de) Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE499351T1 (de) Aryl- und heteroaryl-ethyl-acylguanidinderivate, ihre herstellung und ihre therapeutische anwendung
ATE542806T1 (de) Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
ATE448211T1 (de) 1,2,4-triazinderivate, ihre herstellung und ihre verwendung in der humantherapie
ATE417846T1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
ATE529426T1 (de) N-phenyl-imidazo(1,2-a)pyridincarboxamid- verbindungen, ihre herstellung sowie ihre therapeutische anwendung
ATE543496T1 (de) 3-acylindol-derivate sowie deren herstellung und therapeutische anwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1902054

Country of ref document: EP